XML 59 R28.htm IDEA: XBRL DOCUMENT v3.25.2

Segment Disclosures (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Significant Expense

The table below summarizes the significant expense categories regularly reviewed by the CODM for the three and six months ended June 30:

			Three Months Ended June 30,
			2025						2024
Operating expenses:
Clinical product candidates			$	17,710					$	14,931
Pre-clinical product candidates			231						219
Employee costs- research and development			2,594						1,887
Employee costs-general and administrative			2,083						1,348
Non-cash stock compensation			1,899						1,882
Depreciation expense			43						34
Professional fees and other segment expenses			2,523						2,513
Total operating expenses			27,083						22,814
Loss from operations			(27,083)						(22,814)
Interest income			241						998
Other income (expense)			22						436
Net loss			$	(26,820)					$	(21,380)
			Six Months Ended June 30,
			2025						2024
Operating expenses:
Clinical product candidates			$	35,491					$	29,882
Pre-clinical product candidates			345						400
Employee costs- research and development			4,761						3,881
Employee costs-general and administrative			3,643						2,704
Non-cash stock compensation			3,941						4,632
Depreciation expense			86						57
Professional fees and other segment expenses			5,641						5,139
Total operating expenses			53,908						46,695
Loss from operations			(53,908)						(46,695)
Interest income			424						2,185
Change in fair value of the tranche rights			—						(4,796)
Other income (expense)			1,191						(1,658)
Net loss			$	(52,293)					$	(50,964)

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration